Resource to Advance Pediatric and HIV Prevention Science (RAPPS): Bioanalytical Support Services

资源促进儿科和艾滋病毒预防科学合同的目的是为校外科学界提供研究材料和临床前产品开发支持，这些候选产品是由研究人员发起的研究或与私营部门或学术伙伴合作产生的。这些服务还可以用于支持产品发现和开发，从而向FDA提交IND、研究设备豁免(IDE)和/或新药申请(NDA)申请。NIAID将主要使用这些合同来更快、更有效地填补关键的开发和资源缺口，并将有前途的产品推进到临床测试中。这些合同的重点将是开发艾滋病毒的治疗和预防产品，包括具有抗相关联合感染活性的单一或组合产品或包含避孕药的MPTS。

The objective of the Resource to Advance Pediatrics and HIV Prevention Science contracts is to provide the extramural scientific community with research materials and preclinical product development support for candidate products that emerge from investigator-initiated research studies, or from collaborations with private sector or academic partners. These services may also be used to support product discovery and development leading to IND, Investigational Device Exemption (IDE), and/or New Drug Application (NDA) filings with the FDA. NIAID will primarily use these contracts to fill critical development and resource gaps more rapidly and efficiently and advance promising products into clinical testing. The focus of these contracts will be development of therapeutics and prevention products for HIV, including single or combination products with activity against associated co-infections or MPTs that incorporate contraceptives.